The Pelvis External Fixation System Market Size is valued at USD 10.25 billion in 2023 and is predicted to reach USD 17.98 billion by the year 2031 at a 7.5% CAGR during the forecast period for 2024-2031.
A pelvis external fixation system is a medical device that is employed to immobilize and stabilize the pelvis following severe trauma or fractures. It is composed of external rods and clamps that are connected by pins or screws that are implanted into the pelvic bones. In emergency situations, this system is frequently implemented to mitigate pain, regulate haemorrhage, and forestall additional injuries.
The Pelvis External Fixation System Market is driven by key factors like the increasing incidence of pelvic fractures and trauma from road accidents, falls, and sports injuries, which boosts demand for effective fixation systems. Advancements in medical technology, the growing geriatric population prone to fractures, rising awareness and adoption of advanced trauma care solutions, and improvements in healthcare infrastructure, especially in developing regions, further propel market growth. Supportive government initiatives and favourable reimbursement policies also enhance the accessibility and affordability of these medical devices. However, the market faces challenges, including high costs, procedural complexities, limited awareness in certain regions, stringent regulatory requirements, and competition from alternative treatments and internal fixation devices.
Competitive Landscape
Some Major Key Players In The Pelvis External Fixation System Market:
- DePuy Synthes (Medical Devices Business Services, Inc)
- Orthofix Medical Inc
- Stryker Corporation
- Smith & Nephew
- Acumed
- Zimmer Biomet
- Baumer S.A.
- Globus Medical
- Orthosynthesis (Ortosintese)
- SOFEMED
- Advanced Orthopaedic Solutions
- Fixus B.V.
- Citieffe
- Zimed Medikal
- TST Orthopedic Implants
- WishBone Medical
- Wuhan Yijiabao Biological Materials
- Other Market Players
Market Segmentation:
The Pelvis External Fixation System Market can be segmented by type and application. By type, the market includes tubular and circular fixation systems. By application, it is divided into primary pelvic congestion syndrome and secondary pelvic congestion syndrome.
Based On Type, The Primary Pelvic Congestion Syndrome Segment Is Accounted As A Major Contributor In The Pelvis External Fixation System Market.
In the Pelvis External Fixation System Market, primary pelvic congestion syndrome holds the largest share. This indicates a higher demand and usage of fixation systems for managing primary pelvic congestion syndrome compared to secondary pelvic congestion syndrome. The focus on this condition underscores its prevalence and the necessity for effective treatment options within the market. In the Pelvis External Fixation System Market, primary pelvic congestion syndrome holds the largest share, reflecting its significant impact on the demand for fixation systems. This condition is more prevalent, requiring effective and reliable treatment options. Consequently, manufacturers and healthcare providers focus on addressing the needs associated with primary pelvic congestion syndrome through innovative and advanced fixation systems. The dominance of this segment underscores the importance of specialized solutions for managing complex pelvic conditions and highlights the market's responsiveness to specific medical requirements.
The Tubular Segment Witnessed Growth At A Rapid Rate.
The dominance of the Tubular segment in the pelvic external Fixation System Market signifies its pivotal role and widespread acceptance among healthcare providers and surgeons. These systems are preferred for their versatility and effectiveness in stabilizing pelvic fractures through adjustable rods and pins tailored to patient anatomy. Clinically, they excel in reducing pain, enabling early mobility, and promoting bone healing, which is crucial for patient recovery. Their widespread adoption, supported by ongoing technological advancements in materials and design, underscores their reliability and integration into surgical practices. Overall, the Tubular segment's leadership in the market reflects its pivotal contribution to advancing treatment standards and meeting clinical needs in pelvic fracture management.
In The Region, The North American Pelvis External Fixation System Market Holds A Significant Revenue Share.
The North American pelvis External Fixation System market is expected to register the highest market share in terms of revenue in the near future. In North America, for instance, the market is characterized by robust healthcare facilities and high healthcare expenditure, driving demand for advanced fixation systems. In addition, Asia Pacific is projected to grow at a rapid rate in the global Pelvis External Fixation System market. The Asia-Pacific region shows rapid market growth fueled by increasing healthcare investments, rising awareness about trauma care, and expanding access to surgical treatments. Each region's market dynamics reflect local healthcare needs, economic conditions, and regulatory landscapes, shaping the adoption and evolution of external fixation systems for pelvic fractures.
Recent Developments:
- In March 2024, Stryker unveiled the availability of its Gamma4 Hip Fracture Nailing System in the majority of European markets. The latest iteration of the Gamma system offers surgeons an advanced version of Stryker's intramedullary nailing method. The primary objective of the Gamma4 system is to address hip and femur fractures and optimize procedural processes for surgeons. In September 2023, the system received the CE certification in Europe.
- In January 2021, Aike (Shanghai) Medical Equipment Co., Ltd obtained US FDA approval for their Bfix® Orthopedic External Fixator Systems.
Pelvis External Fixation System Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 10.25 Bn |
|
Revenue Forecast In 2031 |
USD 17.98 Bn |
|
Growth Rate CAGR |
CAGR of 7.5% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type and Application. |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
DePuy Synthes (Medical Devices Business Services, Inc), Orthofix Medical Inc, Stryker Corporation, Smith & Nephew, Acumed, Zimmer Biomet, Baumer S.A., Globus Medical, Orthosynthesis (Ortosintese), SOFEMED, Advanced Orthopaedic Solutions, Fixus B.V., Zimed Medical, and others. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
